![David Vied](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 83 301 $ in data 31/05/2026
David L.
Vied currently works at Cyanotech Corp., as Independent Director from 2015, Anavasi Diagnostics, as Director from 2022, and Korn Ferry, as Global Sector Leader-Medical Devices & Diagnostics.
Mr. Vied received his undergraduate degree from The California State University and graduate degree from the University of North Texas.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/08/2025 | 225.138 ( 3,05% ) | 83 301 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CYANOTECH CORPORATION | Direttore/Membro del Consiglio | 27/01/2015 |
| KORN FERRY | Corporate Officer/Principal | - |
Anavasi Diagnostics
 Anavasi Diagnostics Medical SpecialtiesHealth Technology Operates as a medical technology company that develops molecular diagnostic testing | Direttore/Membro del Consiglio | 02/11/2022 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Cyanotech Corp.
 Cyanotech Corp. Pharmaceuticals: OtherHealth Technology Develops and markets natural products | Health Technology |
Korn Ferry
 Korn Ferry Personnel ServicesCommercial Services Provides organizational consulting, executive search and talent management services | Commercial Services |
The California State University
 The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of North Texas
 University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anavasi Diagnostics
Anavasi Diagnostics Medical SpecialtiesHealth Technology Operates as a medical technology company that develops molecular diagnostic testing | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
